PENCO, MARIA
 Distribuzione geografica
Continente #
NA - Nord America 11.055
EU - Europa 6.118
AS - Asia 5.838
SA - Sud America 589
AF - Africa 63
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 7
Totale 23.681
Nazione #
US - Stati Uniti d'America 10.954
SG - Singapore 2.244
IE - Irlanda 1.481
CN - Cina 1.430
RU - Federazione Russa 957
TR - Turchia 852
IT - Italia 783
SE - Svezia 702
DE - Germania 602
HK - Hong Kong 535
BR - Brasile 501
UA - Ucraina 449
GB - Regno Unito 422
VN - Vietnam 395
FR - Francia 301
FI - Finlandia 232
IN - India 94
BD - Bangladesh 65
CA - Canada 46
JP - Giappone 43
AR - Argentina 37
NL - Olanda 33
CZ - Repubblica Ceca 30
BE - Belgio 27
MX - Messico 27
ZA - Sudafrica 24
ID - Indonesia 21
ES - Italia 18
IQ - Iraq 17
PK - Pakistan 17
AT - Austria 16
MY - Malesia 15
PL - Polonia 14
UZ - Uzbekistan 14
AE - Emirati Arabi Uniti 12
IL - Israele 10
PH - Filippine 10
TH - Thailandia 10
EU - Europa 9
JM - Giamaica 9
JO - Giordania 9
NP - Nepal 9
CH - Svizzera 8
CL - Cile 8
CO - Colombia 8
EC - Ecuador 8
KE - Kenya 8
MA - Marocco 8
RO - Romania 8
PY - Paraguay 7
VE - Venezuela 7
KR - Corea 6
SA - Arabia Saudita 6
TN - Tunisia 6
AU - Australia 5
PT - Portogallo 5
UY - Uruguay 5
BO - Bolivia 4
CR - Costa Rica 4
EG - Egitto 4
MD - Moldavia 4
MT - Malta 4
OM - Oman 4
PE - Perù 4
BG - Bulgaria 3
LT - Lituania 3
RS - Serbia 3
SN - Senegal 3
TW - Taiwan 3
AL - Albania 2
BB - Barbados 2
BH - Bahrain 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
ET - Etiopia 2
HN - Honduras 2
HR - Croazia 2
KW - Kuwait 2
KZ - Kazakistan 2
MN - Mongolia 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AD - Andorra 1
AO - Angola 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CG - Congo 1
DM - Dominica 1
EE - Estonia 1
GD - Grenada 1
GE - Georgia 1
HT - Haiti 1
HU - Ungheria 1
IR - Iran 1
KH - Cambogia 1
Totale 23.668
Città #
Jacksonville 1.779
Chandler 1.488
Dublin 1.480
Singapore 1.213
San Jose 991
Dallas 706
Boardman 561
Ashburn 541
Hong Kong 524
Santa Clara 519
Izmir 399
Council Bluffs 327
Nanjing 317
San Mateo 315
The Dalles 285
Wilmington 277
New York 237
Moscow 231
Princeton 227
Lawrence 226
Lauterbourg 154
Ho Chi Minh City 139
Ann Arbor 134
Milan 126
Beijing 120
Nanchang 108
Hanoi 100
Seattle 88
Shenyang 88
Des Moines 78
Verona 74
Los Angeles 71
Hefei 69
Tianjin 69
Hebei 65
Woodbridge 65
Rome 64
L’Aquila 63
Kunming 49
Bremen 45
São Paulo 45
Jinan 44
Tokyo 39
Jiaxing 38
Munich 37
Changsha 35
Frankfurt am Main 35
Mountain View 35
Helsinki 34
Orem 34
L'aquila 31
Norwalk 30
Columbus 28
Brussels 27
Zhengzhou 27
Guangzhou 26
Pune 25
Brno 23
Da Nang 23
Brooklyn 22
Chennai 22
Dearborn 21
Philadelphia 21
Ningbo 19
Rio de Janeiro 19
Shanghai 18
Falls Church 17
Belo Horizonte 16
Atlanta 15
Chicago 15
Haiphong 15
Hangzhou 15
Johannesburg 15
Stockholm 15
Denver 14
Tashkent 14
Toronto 14
Fremont 13
Warsaw 13
Houston 12
Lanzhou 12
Taizhou 12
Turin 12
Boston 11
Fuzhou 11
London 11
Montreal 11
Mexico City 10
Nuremberg 10
Bangkok 9
Biên Hòa 9
Bologna 9
San Francisco 9
Vienna 9
Amsterdam 8
Florence 8
Goiânia 8
Amman 7
Brasília 7
Campobasso 7
Totale 15.563
Nome #
. La prescrizione dell’esercizio fisico in ambito cardiologico. Documento Cardiologico di Consenso della Tak Force Multisocietaria FMSI, SIC Sport, ANCE, ANMCO, GICR, SIC. FMSI e SIC Sport 316
Protocolli cardiologici per il giudizio di idoneità allo sport agonistico 2003 187
Usefulness of echocardiography in the prognostic evaluation of non-Q-wave myocardial infarction 161
Italian Cardiological Guidelines (COCIS) for Competitive Sport Eligibility in athletes with heart disease: update 2020 158
Analysis of Risk Factors Independently Associated with Cognitive Impairment in Patients with Permanent Atrial Fibrillation: A Cross-sectional Observational Study 151
Visita medico sportiva: è sostenibile l'introduzione di un ecocardiogramma focused? 147
Clinical profile of patients with heart failure can predict rehospitalization and quality of life 147
Unravelling the interplay between hyperkalaemia, renin–angiotensin–aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term Registry 146
Accuracy of N-terminal pro-brain natriuretic peptide in the identification of left ventricular dysfunction in high-risk asymptomatic patients 137
Dose-dense nonpegylated liposomal doxorubicin and docetaxel combination in breast cancer: Dose-finding study 137
Influence of acute exercise on human platelet responsiveness: possible involvement of exercise-induced oxidative stress. 133
Association between corrected QT interval and C-reactive protein in patients with inflammatory bowel diseases 133
Determinants of operator radiation exposure during percutaneous coronary procedures 131
Acute heart failure congestion and perfusion status – impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry 128
Care manager to control cardiovascular risk factors in primary care: The Raffaello cluster randomized trial 127
Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC-EORP Heart Failure Long-Term Registry 127
Bilateral internal mammary artery for multi-territory myocardial revascularization: long-term follow-up of pedicled versus skeletonized conduits† 125
Novel insights in pathophysiology of antiblastic drugs-induced cardiotoxicity and cardioprotection 125
Increased cardiovascular events and subclinical atherosclerosis in rheumatoid arthritis patients: 1 year prospective single centre study 124
The impact of right ventricular function upon 2-year actual cardiac mortality of patients with ischemic mitral regurgitation undergoing mitral valve surgery 124
Mitral valve repair for dilated cardiomyopathy: predictive role of right ventricular dysfunction 123
Possible involvement of increased susceptibility of LDL to oxidation in age-related platelet activation 123
[ACE-inhibitors after infarction: current knowledge and future prospects]. FT ACE-inibitori nel postinfarto: conoscenze consolidate e prospettive future. 123
A New Electrocardiographic Marker of Sudden Death in Brugada Syndrome: The S-Wave in Lead I 123
[Transesophageal stress echocardiography]. FT Eco-stress transesofageo. 123
Echocardiography in the Coronary Care Unit: diagnostic and prognostic impact in comparison with clinical and other indicators 120
Continuous ECG Monitoring in Patients With Acute Coronary Syndrome or Heart Failure: EASI Versus Gold Standard 120
Italian cardiological guidelines for sports eligibility in athletes with heart disease: part 1. 118
[Aspects of pulmonary circulation in pneumocardiopathies]. FT Aspetti del circolo polmonare nelle pneumocardiopatie. 118
Role of MRI in the diagnosis of arrhythmic right ventricular dysplasia 118
Prevalence of Chlamydia Pneumoniae in peripheral blood mononuclear cells in italian patients with acute ischaemic heart disease 117
The PREHAMI (PREsillion in high-risk acute myocardial infarction) registry: In-hospital and long-term outcomes 117
A comparison between EASI system 12-lead ECGs and standard 12-lead ECGs for improved clinical nursing practice 117
[Ventricular hypertrophy and essential arterial hypertension: an echocardiographic study]. FT Ipertrofia ventricolare e ipertensione arteriosa essenziale: studio ecocardiografico. 116
[Stress echocardiography in the study of the warm-up phenomenon]. FT L'ecocardiografia da sforzo nello studio del fenomeno del warm-up. 116
The role of bariatric surgery for improvement of hypertension in obese patients: A retrospective study 116
Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long-Term Registry 116
Electrocardiographic voltage criteria in patients with hypertrophic cardiomyopathy 116
Relation between coronary atherosclerotic plaques and traditional risk factors in people with no history of cardiovascular disease undergoing multi-detector computed coronary angiography 116
[Infective agents in the pathogenesis of ischemic cardiopathy]. FT Agenti infettivi nella patogenesi della cardiopatia ischemica. 115
Appropriateness in echocardiography and clinical priority classification criteria: a proposal from the Italian Society of Cardiovascular Echography 115
Timing and magnitude of regional right ventricular function: a speckle tracking-derived strain study of normal subjects and patients with right ventricular dysfunction 115
Structure, production and function of erythropoietin: implications for therapeutical use in cardiovascular disease 115
Test da sforzo precoce nel post-infarto: validita' nella valutazione dell'entita' della compromissione coronarica. 115
Radial artery occlusion and hand strength after percutaneous coronary procedures: Results of the HANGAR study 115
Repair or prosthesis insertion in ischemic mitral regurgitation: Two faces of the same medal 115
Rationale and design of TRAPS (LefT atRial ApPendage occluSion italian multicenter registry) study 115
Sport activity in patients with cardiac implantable electronic devices: evidence and perspectives 115
The management of echocardiography in Italy. Consensus conference of the Italian Society of Cardiovascular Echography (SIEC) | [Dalla formazione degli operatori al referto. Documento di consenso sugli aspetti organizzativi dell'ecocardiografia in Italia] 114
Ventricular Mechanical Asynchrony in Patients with Different Degrees of Systolic Dysfunction: Results from AVE Registry by the Italian Society of Cardiovascular Echography (SIEC) 114
Protocolli cardiologici per il giudizio di idoneità allo sport agonistico 114
Influence of reperfusion induced by thrombolytic treatment on natural hystory of regional wall motion abnormality in acute myocardial infarction 113
A super-normal behaviour of echocardiographic diastolic data in athletes despite left ventricular hypertrophy. 113
[The variability of the heart rate in patients with a myocardial infarct undergoing systemic fibrinolysis interventions]. FT Variabilita della frequenza cardiaca in pazienti con infarto miocardico sottoposti ad interventi di fibrinolisi per via sistemica. 113
[Calcium antagonists: an echocardiographic evaluation of the morphofunctional changes in the left ventricle]. FT Calcioantagonisti: valutazione ecocardiografica delle modificazioni morfofunzionali del ventricolo sinistro. 113
Operator Pelvic Radiation Exposure during Percutaneous Coronary Procedures 113
Clinical, humoral and echocardiographic profile of patients with heart failure can predict long-term quality of life. 113
Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world 113
Yield and clinical significance of genetic screening in elite and amateur athletes 113
Effectiveness of thrombolysis is associated with a time-dependent increase of malondialdehyde in peripheral blood of patients with acute myocardial infarction. 112
Linee Guida per l’uso appropriato delle metodiche diagnostiche non invasive 112
Iperlipidemia, fattori emocoagulativi, fattori eredo-familiari e aterosclerosi coronarica. 112
Measurements of mechanical asynchrony in patients with heart failure: is the puzzle completed? 112
Possibilità e limiti della risonanza magnetica nell’iter diagnostico della cardiomiopatia aritmogena del ventricolo destro 112
Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction: role of MRI 111
Evaluation of ventriculo-arterial coupling in ST elevation myocardial infarction with left ventricular dysfunction treated with levosimendan 111
Meta-Regression to Identify Patients Deriving the Greatest Benefit from Dual Antiplatelet Therapy after Stroke or Transient Ischemic Attack Without Thrombolytic or Thrombectomy Treatment. 111
[Usefulness of stress echocardiography in the evaluation of clinical and functional success of coronary angioplasty and prognostic stratification]. FT Utilita dell'ecocardiografia da sforzo per la valutazione del successo clinico e funzionale dell'angioplastica coronarica e per la stratificazione prognostica. 110
LINEE GUIDA: Linee guida per la diagnosi e la terapia dell’angina instabile. Aggiornamento 2000. 110
Aspetti morfologici e funzionali dell'ipertrofia ventricolare sinistra valutata attraverso la lettura computerizzata dei tracciati ecocardiografici 109
Digitalis and ACE inhibitors in the treatment of congestive heart failure 109
Progetto Raffaello :Valutazione di efficacia di un modello di disease and care management in prevenzione delle patologie cardiovascolari” 108
Impact of environmental pollution and weather changes on the incidence of ST-elevation myocardial infarction 108
Influence of residual perfusion within the infarct zone on the natural history of left ventricular dysfunction after acute myocardial infarction: a myocardial contrast echocardiographic study. 107
Italian cardiological guidelines for sports eligibility in athletes with heart disease: part 2. 107
[Myocardial protection: a look to the future]. FT Protezione miocardica: uno sguardo verso il futuro. 107
Radiation dose absorbed by operators during transradial percutaneous coronary procedures comparing different protective drapes: The RADIATION study 107
Left ventricular surgical remodelling: is it a matter of shape or volume? 106
Interet de l'echocardiographie en mode M dans la diagnostique de l'hypertension pulmonaire. 106
Should sports activity be encouraged or contraindicated in hypertensive subjects? 106
2D exercise echocardiography in athletes. A study of the mechanisms responsible for the increase in the ejection fraction. 106
Valutazioni seriate del peptide natriuretico cerebrale sono predittive di cardiotossicità da antracicline in pazienti sottoposti a chemioterapia non ad alte dosi 106
Modificazioni fisiologiche del tono nervoso autonomo alla luce delle nuove metodologie di studio 106
Role of biomarkers in monitoring antiblastic cardiotoxicity 106
Modifications of whole blood filterability during acute myocardial infarction 106
Le complicanze dell'infarto miocardico 105
Influence of aging and exercise-induced stress on human platelet function 105
Miocardio a rischio dopo infarto miocardico acuto trattato con fibrinolisi: rilevamento mediante ecocardiografia da sforzo e significato clinico-prognostico. 105
Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry 105
Ruolo dell'ecocardiografia in Cardiologia dello sport ai fini di un corretto giudizio di idoneita' allo sport agonistico. 104
Clinical impact of echocardiography in prognostic stratification after acute myocardial infarction 104
Non-vitamin K antagonist oral anticoagulants and sport 104
Serial changes in longitudinal strain are associated with outcome in children with hypoplastic left heart syndrome 104
[Calcium antagonists: hemodynamic effects in hypertensive patients]. FT Calcioantagonisti: effetti emodinamici nell'iperteso. 103
Early diagnosis of left ventricular diastolic dysfunction in diabetic patients: a possible role for natriuretic peptides 103
[The use of stress echocardiography in the assessment of results of myocardial revascularizations interventions]. FT Impiego dell'ecocardiografia da stress nella valutazione dei risultati di interventi di rivascolarizzazione miocardica. 103
Exercise imaging approaches to ischemic heart disease: echocardiography versus myocardial scintigraphy. 103
Operator radiation exposure during right or left transradial coronary angiography: A phantom study 103
[Comparison of provocation tests based on physiopathologic mechanisms: suggestions for the clinician]. FT Raffronto tra test provocativi sulla base dei meccanismi fisiopathologici: indicazioni per il clinico. 102
[Evaluation of ischemic risk in infarct patients submitted for fibronolysis: how and when should it be carried out?]. FT Valutazione del rischio ischemico nel paziente infartuato sottoposto a fibrinolisi: come e quando effettuarla? 102
Totale 11.879
Categoria #
all - tutte 101.544
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 101.544


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202183 0 0 0 0 0 0 0 0 0 0 0 83
2021/20221.417 79 170 290 86 52 16 14 90 80 21 95 424
2022/20234.413 332 249 118 361 450 454 6 279 1.922 25 120 97
2023/20241.066 222 62 51 186 71 253 32 96 5 31 9 48
2024/20253.651 49 52 381 120 439 339 413 325 870 201 217 245
2025/20266.674 308 699 381 766 634 608 1.232 279 593 547 536 91
Totale 23.814